Update on cutaneous drug reactions.
Wolverton
S E
SE
Department of Dermatology, Indiana University Medical Center, Indianapolis, USA.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D002121:Calcium Channel Blockers / Q000009:adverse effects; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology; D006635:Histamine H2 Antagonists / Q000009:adverse effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects; D054328:Proton Pump Inhibitors
D000806:Angiotensin-Converting Enzyme Inhibitors; D000927:Anticonvulsants; D002121:Calcium Channel Blockers; D006635:Histamine H2 Antagonists; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D054328:Proton Pump Inhibitors